Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon

1Q Revenues: $171.7 million (+9%)

1Q Loss: $2.6 million (loss of $11.5 million 1Q2006)

Comments: Revenues from Rx manufacturing services grew 13% to $14.2 million, reflecting higher volumes at the Canadian, European and PR operations. Pharmaceutical development services (PDS) revenues increased 23% to $5 million, due to growth at the Toronto, Cincinnati and Swindon operations. Repositioning expenses — related to workforce reduction and the expansion of the company’s manufacturing efficiency review process — were $3.7 million in the quarter. During the quarter, the company further reduced the size of its global workforce by approximately 300 positions, or 5%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters